Clinical course and outcomes of single-organism enterococcus peritonitis in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 31, Issue 5, 2011, Pages 522-528

  Yip, Terence ^a   Tse, Kai Chung ^a   Ng, Flora ^a   Hung, Ivan ^a   Lam, Man Fai ^a   Tang, Sydney ^a   Lui, Sing Leung ^a   Lai, Kar Neng ^a   Chan, Tak Mao ^a   Lo, Wai Kei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Enterococcus peritonitis; Renal failure

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; NETILMICIN; TOBRAMYCIN; VANCOMYCIN;

AGED; AMPICILLIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTEROCOCCAL PERITONITIS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HAZARD RATIO; HEMODIALYSIS PATIENT; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ABDOMINAL PAIN; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84856138178     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00260     Document Type: Review

References (28)

1. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20:396-411.
2. Boost M, Lai L, O'Donoghue M. Drug resistance in fecal enterococci in Hong Kong. J Infect Chemother 2004; 10:326-30.
3. Chuang VW, Tsang DN, Lam JK, Lam RK, Ng WH. An active surveillance study of vancomycin-resistant Enterococcus in Queen Elizabeth Hospital, Hong Kong. Hong Kong Med J 2005; 11:463-71.
4. Ling JM, Char TS, Cheng AF. Distribution of enterococci in Hong Kong. J Infect 2002; 45:257-62.
5. American National Standards Institute, National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for bacteria That Grow Aerobically. 4th ed. Wayne, PA: NCCLS; 1997.
6. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
7. Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol 1992; 30:2373-8.
8. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342:710-21.
9. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13:19046.
10. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-61.
11. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1:57-8.
12. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33:1588-91.
13. Cheng AF, Char TS, Ling JM. Are multiply resistant enterococci a common phenomenon in Hong Kong? J Antimicrob Chemother 2002; 50:761-3.
14. Ho PL, Hong Kong Intensive Care Unit Antimicrobial Resistance Study (HK-ICARE) Group. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 2003; 31:1175-82.
15. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38:1363-7.
16. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995; 23:170-80.
17. Willems RJ, Bonten MJ. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Curr opin Infect Dis 2007; 20:384-90.
18. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9:454-60.
19. Fortun J, Coque TM, Martin-Davila P, Moreno L, Canton R, Loza E, et al. Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. J Antimicrob Chemother 2002; 50:1003-9.
20. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of beta-lactamase-negative, ampicillin-resistant Enterococcus. Arch Intern Med 1992; 152:1457-61.
21. Berg RD, Wommack E, Deitch EA. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 1988; 123:1359-64.
22. Yip T, Tse KC, Lam MF, Tang S, Li FK, Choy BY, et al. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int 2006; 26:191-7.
23. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network9 Peritonitis Study. Kidney Int 1997; 52:524-9.
24. Munoz de Bustillo E, Aguilera A, Jimenez C, Bajo MA, Sanchez C, Selgas R. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study. Perit Dial Int 1997; 17:392-5.
25. Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 2010; 25:1272-8.
26. Montravers P, Mohler J, Saint Julien L, Carbon C. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 1997; 65:144-9.
27. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001; 135:175-83.
28. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16:750-5.